Novartis Drug Fails Key Study for Rare Neuromuscular Condition
The company's second major trial collapse in days follows the failure of its heart disease drug Pelacarsen.
5 stories · RSS
The company's second major trial collapse in days follows the failure of its heart disease drug Pelacarsen.
Latest research suggests injectable grafts could provide an alternative to transplantation.
A letter from filmmaker Jonathan de Jong highlights that dementia patients often dread losing their sense of self more than the disease itself.
A qualitative study finds that girl-led education improves stakeholder perceptions and experiences regarding iron-folic acid supplementation for pregnant women.
A medication originally developed for arthritis is demonstrating unexpected efficacy in treating alopecia areata, the second most common form of hair loss worldwide.